ORNBV:HEL
Orion Oyj Class B
€80.85
arrow_upward
+0.06%(+0.050) 1D
Oct 5, 6:29:49 PM GMT+3 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORNBV...
Open
€80.80
High
€81.65
Low
€80.60
Mkt. cap
11.34B
Avg. vol.
152.33K
Volume
111.45K
Dividend
2.23%
Quarterly dividend
€0.45
Ex-dividend date
Oct 15, 2025
P/E ratio
19.37
52-wk high
€84.60
52-wk low
€56.50
EPS
€4.17
Shares outstanding
109.86M
No. of employees
4K
Open
€80.80
High
€81.65
Low
€80.60
Mkt. cap
11.34B
Avg. vol.
152.33K
Volume
111.45K
Dividend
2.23%
Quarterly dividend
€0.45
Ex-dividend date
Oct 15, 2025
P/E ratio
19.37
52-wk high
€84.60
52-wk low
€56.50
EPS
€4.17
Shares outstanding
109.86M
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
8 hours ago
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
AD HOC NEWS
·
9 hours ago
Orion completes buyback as Orion stock sits 3.84 percent below high
AD HOC NEWS
·
1 day ago
Orion stock completes a 500,000 share buyback
Profile
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
About Orion Oyj Class B
CEOLiisa Hurme
Employees4K
FoundedSep 21, 1917
Headquarters-
SectorPharmaceutical industry
Websiteorionpharma.com